Andrea Pfeifer

Founder at AC IMMUNE SA

Net worth: 6 M $ as of 29/04/2024

66 year

86 connections

Finance

Health Technology

Consumer Services

Active connections

Name	Gender	Age	Linked companies	Collaboration
Douglas Williams	M	66	AC IMMUNE SA	6 years
Piergiorgio Donati	M	54	AC IMMUNE SA	11 years
Bernd Hirsch	M	53	SYMRISE AG	15 years
Monica Shaw	M	46	AC IMMUNE SA	3 years
Harald Feist	M	61	SYMRISE AG	18 years
Oliver Sol	M	58	AC IMMUNE SA	8 years
Jean-Yves Parisot	M	60	SYMRISE AG	8 years
Michael König	M	60	SYMRISE AG	4 years
Monika Bütler	M	63	AC IMMUNE SA	3 years
Daniel Hayoz	M	-	University of Lausanne	-
Roy Ervin Twyman	M	68	AC IMMUNE SA	5 years
Andre Kirchhoff	M	58	SYMRISE AG	8 years
Jean-Fabien Monin	M	54	AC IMMUNE SA	15 years
Jakob Ley	M	57	SYMRISE AG	-
Carl June	M	70	AC IMMUNE SA	4 years
Barthélemy Helg	M	58	AB2 Bio SA AB2 Bio SA Pharmaceuticals: MajorHealth Technology AB2 Bio SA develops and manufactures drugs. The firm's products include Interleukin-18 Binding Protein and Proprietary Assay. The company was founded in 2010 and is headquartered in Lausanne, Switzerland.	14 years
Gary Waanders	M	60	AC IMMUNE SA	-
Werner Lanthaler	M	56	AC IMMUNE SA	6 years
Christopher Roberts	M	35	AC IMMUNE SA	5 years
Julian Snow	M	-	AC IMMUNE SA	-
Andrea Püttcher	M	46	SYMRISE AG	-
Alexandre Caratsch	M	59	AC IMMUNE SA	6 years
Julien Rongère	M	47	AC IMMUNE SA	7 years
Howard Donovan	M	49	AC IMMUNE SA	2 years
Bojana Portmann	M	43	AC IMMUNE SA	13 years
Carlo Lombardini	M	60	University of Lausanne	14 years
Mehdi Tafti	M	66	University of Lausanne	13 years
Jeannette Chiarlitti	F	42	SYMRISE AG	-
Mark Danton	M	60	AC IMMUNE SA	5 years
Djordje Filipovic	M	-	AB2 Bio SA AB2 Bio SA Pharmaceuticals: MajorHealth Technology AB2 Bio SA develops and manufactures drugs. The firm's products include Interleukin-18 Binding Protein and Proprietary Assay. The company was founded in 2010 and is headquartered in Lausanne, Switzerland.	-
Adriano Aguzzi	M	-	AB2 Bio SA AB2 Bio SA Pharmaceuticals: MajorHealth Technology AB2 Bio SA develops and manufactures drugs. The firm's products include Interleukin-18 Binding Protein and Proprietary Assay. The company was founded in 2010 and is headquartered in Lausanne, Switzerland.	-
Peter Vanacker	M	58	SYMRISE AG	4 years
Olivier Verscheure	M	52	University of Lausanne	6 years
Tobias Erfurth	M	-	SYMRISE AG	13 years
Gerald D. Cagle	M	79	AB2 Bio SA AB2 Bio SA Pharmaceuticals: MajorHealth Technology AB2 Bio SA develops and manufactures drugs. The firm's products include Interleukin-18 Binding Protein and Proprietary Assay. The company was founded in 2010 and is headquartered in Lausanne, Switzerland.	-
Bénédict G. F. Hentsch	M	76	AB2 Bio SA AB2 Bio SA Pharmaceuticals: MajorHealth Technology AB2 Bio SA develops and manufactures drugs. The firm's products include Interleukin-18 Binding Protein and Proprietary Assay. The company was founded in 2010 and is headquartered in Lausanne, Switzerland.	-
Diego Braguglia	M	58	AB2 Bio SA AB2 Bio SA Pharmaceuticals: MajorHealth Technology AB2 Bio SA develops and manufactures drugs. The firm's products include Interleukin-18 Binding Protein and Proprietary Assay. The company was founded in 2010 and is headquartered in Lausanne, Switzerland.	-
Olaf Klinger	M	59	SYMRISE AG	8 years
Thomas Steinmann	M	63	University of Lausanne	29 years
Guy Mustaki	M	64	University of Lausanne	33 years
Jan Zijderveld	M	60	SYMRISE AG	-
Ursula Buck	F	62	SYMRISE AG	8 years
Sonia Maria Poli	M	59	AC IMMUNE SA	7 years
Patrick Chareyre	M	-	University of Lausanne	-
Reinhard Mühe	M	-	SYMRISE AG	18 years
Christina Witter	F	-	SYMRISE AG	14 years
Thomas D. Szucs	M	64	AB2 Bio SA AB2 Bio SA Pharmaceuticals: MajorHealth Technology AB2 Bio SA develops and manufactures drugs. The firm's products include Interleukin-18 Binding Protein and Proprietary Assay. The company was founded in 2010 and is headquartered in Lausanne, Switzerland.	-
Madiha Derouazi	M	51	AC IMMUNE SA	-
Jörn Andreas	M	44	SYMRISE AG	-
Nuno Mendonça	M	42	AC IMMUNE SA	1 years

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
Martin Velasco	M	70	AC IMMUNE SA	18 years
Thomas Hermann Rabe	M	58	SYMRISE AG	10 years
Winfried Steeger	M	73	SYMRISE AG	8 years
Alan Colowick	M	61	AC IMMUNE SA	2 years
Friedrich von Bohlen und Halbach	M	60	AC IMMUNE SA	5 years
Jeannette Härtling	F	42	SYMRISE AG	-
Peter Bollmann	M	71	AC IMMUNE SA	6 years
George Pavey	M	-	AC IMMUNE SA	2 years
Thomas Graney	M	60	AC IMMUNE SA	7 years
Christiane Jarke	F	70	SYMRISE AG	11 years
Hans Holger Gliewe	M	64	SYMRISE AG	5 years
Regina Hufnagel	F	70	SYMRISE AG	-
Hans-Beat Gürtler	M	78	AC IMMUNE SA	-
Detlev Riesner	M	81	AC IMMUNE SA	-
Heinz-Jürgen Bertram	M	65	SYMRISE AG	21 years
Fred van Leuven	M	-	AC IMMUNE SA	-
Béatrice Mouleyre	F	-	SYMRISE AG	-
Jörg Hornstein	M	47	AC IMMUNE SA	-
Heinrich Friedrich Ludwig Schaper	M	67	SYMRISE AG	-
Ludwig Tumbrink	M	71	SYMRISE AG	-
Andreas G. Schmid	M	67	SYMRISE AG	4 years
Sanna Suvanto-Harsaae	F	58	SYMRISE AG	4 years
Arnaud Bellon	M	-	SYMRISE AG	-
Mathias Hothum	M	58	AC IMMUNE SA	-
Roscoe Brady	M	-	AC IMMUNE SA	-
Marie Kosco-Vilbois	M	67	AC IMMUNE SA	5 years
Jean-marie Lehn	M	-	AC IMMUNE SA	-
Claude Nicolau	M	-	AC IMMUNE SA	-
Michael Becker	M	76	SYMRISE AG	7 years
Alexey V. Eliseev	M	-	AC IMMUNE SA	-
Peter Winkelmann	M	65	SYMRISE AG	9 years
Hans-Heinrich Gürtler	M	-	SYMRISE AG	-
Christof Hettich	M	64	AC IMMUNE SA	-
Andreas Muhs	M	62	AC IMMUNE SA	13 years
Ruth Greferath	M	-	AC IMMUNE SA	-
Johannes Streffer	M	56	AC IMMUNE SA	2 years

Statistics

Country	Connections	% of total
Switzerland	54	62.79%
Germany	32	37.21%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections